Dr. Ann Raldow, MD

Claim this profile

UCLA

Studies Rectal Cancer
Studies Stomach Cancer
2 reported clinical trials
7 drugs studied

Area of expertise

1Rectal Cancer
Ann Raldow, MD has run 1 trial for Rectal Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III
2Stomach Cancer
Ann Raldow, MD has run 1 trial for Stomach Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III

Affiliated Hospitals

Image of trial facility.
UCLA
Image of trial facility.
UCLA / Jonsson Comprehensive Cancer Center

Clinical Trials Ann Raldow, MD is currently running

Image of trial facility.

Combination Chemotherapy + Radiation

for Rectal Cancer

This phase I trial investigates how well short-course radiation therapy followed by combination chemotherapy works in treating patients with stage II-III rectal cancer. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as leucovorin, fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving short-course radiation therapy and combination chemotherapy may reduce the need for surgery and therefore improve quality of life.
Recruiting1 award Phase 111 criteria

More about Ann Raldow, MD

Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Ann Raldow, MD has experience with
  • Capecitabine
  • Fluorouracil
  • Intensity-Modulated Radiation Therapy
  • Leucovorin
  • Oxaliplatin
  • Total Mesorectal Excision
Breakdown of trials Ann Raldow, MD has run
Rectal Cancer
Stomach Cancer
Pancreatic Cancer

Other Doctors you might be interested in

Wayne Brisbane, M.D.UCLA
William A. MayMattel Childrens Hospital UCLA
Nicholas P McAndrew, M.D.UCLA / Jonsson Comprehensive Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ann Raldow, MD specialize in?
Ann Raldow, MD focuses on Rectal Cancer and Stomach Cancer. In particular, much of their work with Rectal Cancer has involved Stage II patients, or patients who are Stage I.
Is Ann Raldow, MD currently recruiting for clinical trials?
Yes, Ann Raldow, MD is currently recruiting for 1 clinical trial in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Ann Raldow, MD has studied deeply?
Yes, Ann Raldow, MD has studied treatments such as Capecitabine, Fluorouracil, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Ann Raldow, MD?
Apply for one of the trials that Ann Raldow, MD is conducting.
What is the office address of Ann Raldow, MD?
The office of Ann Raldow, MD is located at: UCLA, Los Angeles, California 90095 United States. This is the address for their practice at the UCLA.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top